about
Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort studyMicronutrient Antioxidants and Nonalcoholic Fatty Liver DiseaseCirculating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular CarcinomaRole of liver transplantation in human immunodeficiency virus positive patientsReview article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of EndocrinologyCombination of diabetes risk factors and hepatic steatosis in Chinese: the Cardiometabolic Risk in Chinese (CRC) StudyNeck circumference, along with other anthropometric indices, has an independent and additional contribution in predicting fatty liver diseaseSonographic assessment of fatty liver: intraobserver and interobserver variability.NAFLD prevalence differs among hispanic subgroups: the Multi-Ethnic Study of Atherosclerosis.Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients.Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis.Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of Kruppel-like-factor 10 in mice.Steatosis and steatohepatitis: complex disorders.Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease.Steatosis and steatohepatitis in postmortem material from Northwestern GreeceAssociation between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese populationNonalcoholic fatty liver disease and aging: epidemiology to management.Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challengePrevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-unitsVitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model.Surgical treatment of nonalcoholic fatty liver disease in severely obese patientsFuture therapy of portal hypertension in liver cirrhosis - a guess.Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.Diagnosing fatty liver disease: a comparative evaluation of metabolic markers, phenotypes, genotypes and established biomarkers.Genetic polymorphisms in non-alcoholic fatty liver disease in obese Egyptian children.Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis.Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.Apparent diffusion coefficient measurements and Gd-DTPA enhanced-imaging in staging hepatic fibrosis in rats.Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study.The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver diseaseSafety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT studyPrevalence of non-alcoholic fatty liver disease in four different weight related patient groups: association with small bowel length and risk factors.Ablation of PI3K p110-α prevents high-fat diet-induced liver steatosisPrevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran.Secondary causes of nonalcoholic fatty liver disease.Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development.
P2860
Q24658538-B8A5A1AE-2479-4453-8599-88FE6648A37DQ26738646-E5DE4DDE-9A58-4852-AD0E-21BE3E95513EQ26767346-7C1D143F-4FA8-4224-BC8E-C2070242BC93Q26775931-DCF02BE9-69E0-4BBC-A1CA-F28EBC8068FEQ26998093-B330A39E-4439-4C83-9900-FFBFBF07651EQ26998471-B6CB8D98-5E9C-4C10-AD09-859AF1ABC65FQ28540317-CB49F2FD-6418-47CD-8941-E9778617C3C0Q28543519-2C038181-B53D-4FB2-9EA4-17E04B0663B5Q30419242-A8166B33-72F7-4097-84CA-D0DC1AA3DED4Q33564139-7FC3DA58-60B3-437C-A4EF-5E95C0E8FFFCQ33573638-57ACD713-5B52-4DAE-B2E8-8995C292BC23Q33735381-39D2F64E-F6D8-4265-B2EC-37D39950EDE8Q33845489-366199F0-FCFA-4697-847B-BE7A715D22A4Q33863032-F988D986-8D71-48A5-ABB6-1E9C94960FECQ33907632-3A2550DC-1084-4905-9402-0A02C16B5E83Q33970970-3541754F-F1EF-4006-AB1F-3E357C467060Q34073625-F31E82FE-355E-4915-AB88-A340103A7962Q34360938-CE00A3F8-F4E8-4BA6-A9B2-356896519190Q34366861-FF2F9019-A9B9-4A49-9927-D3A08B2908C4Q34390296-E155C58E-F418-4F09-8DD0-7A8CD4F82C08Q34415002-C4FFCFC0-FC03-4637-9730-4B4C5843E051Q34439822-BB6AE403-585C-4F8A-8623-88171FBCEFFCQ34446294-1B9E238E-8FC1-498A-982D-7F933952CF50Q34446521-BCE6CD38-A06D-426E-B58C-8C2BD0B41DA2Q34760318-0470681B-70F0-44D6-9191-ED0D00F09CF9Q35018573-24ACDAA8-4197-492E-B511-1AB02EFDAB01Q35098370-8E0637B6-4BD4-4548-9A5A-F0177A3005FBQ35111929-DC7135D9-757B-4B33-A871-BFE2739B6B95Q35444953-05063C86-8DB7-4F6E-B36F-F4848ED8430CQ35480134-942E9C8A-A42C-4570-AD2A-FDF665A1D032Q35563896-E46E620A-7CCD-471F-B660-FB4A2E04A324Q35615790-E5A688B3-8D09-4163-9CE1-C51A3B20276BQ35625381-71E5D686-8564-48A7-8BC2-DE9AF2052AC4Q35674320-8E1C501C-14B3-401F-B768-5BE529E197E5Q35681834-0D0793AB-A86E-45EA-86BC-940024F571D7Q35796978-AD364A69-B076-40C9-87B8-B49B4D42572DQ35846367-341B5091-2A98-46F3-B4FA-2074247D1921Q35929072-4D0E2AAE-0B05-4E58-AD67-2D01AE8A30AAQ36003451-668B99FE-F192-45F8-B5B6-3AC331C2AFE4Q36130937-D93245DA-6B46-473C-959A-250AD7154872
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
GI epidemiology: nonalcoholic fatty liver disease.
@ast
GI epidemiology: nonalcoholic fatty liver disease.
@en
type
label
GI epidemiology: nonalcoholic fatty liver disease.
@ast
GI epidemiology: nonalcoholic fatty liver disease.
@en
prefLabel
GI epidemiology: nonalcoholic fatty liver disease.
@ast
GI epidemiology: nonalcoholic fatty liver disease.
@en
P1476
GI epidemiology: nonalcoholic fatty liver disease.
@en
P2093
P304
P356
10.1111/J.1365-2036.2007.03246.X
P407
P577
2007-04-01T00:00:00Z